FDA advisers recommend new controls on rosiglitazone use

被引：0

|

作者：

Traynor, Kate

机构：

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2010年 / 67卷 / 16期

关键词：

D O I：

10.2146/news100056

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：1306 / 1308

页数：3

相关论文

共 50 条

[1] FDA advisers recommend approval of biosimilar filgrastim
Traynor, Kate
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (04) : 262 - +
[2] FDA advisers favor easing rosiglitazone restrictions
Traynor, Kate
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (14) : 1184 - 1185
[3] FDA advisers recommend that xenotransplant recipients not donate blood
Wilson, K
Wilson, F
[J]. LABORATORY MEDICINE, 2000, 31 (03) : 127 - 127
[4] FDA's advisers recommend updating alosetron's REMS
Thompson, Cheryl A.
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (16) : 1365 - 1366
[5] DNA ADVISERS RECOMMEND THE SAME CONTROLS FOR INDUSTRY AS UNIVERSITIES
DICKSON, D
[J]. NATURE, 1979, 279 (5712) : 360 - 361
[6] FDA ADVISERS SPURN TOUGH DARVON CONTROLS
SMITH, RJ
[J]. SCIENCE, 1979, 204 (4394) : 712 - 713
[7] FDA advisers wary of expanding quetiapine use
Traynor, Kate
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (10) : 880 - +
[8] ADVISERS CALL FOR NEW CONTROLS ON PHTHALATES
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2014, 92 (30) : 23 - 23
[9] US FDA advisers back new myopia aid
Ault, A
[J]. LANCET, 1999, 353 (9149): : 300 - 300
[10] Rosiglitazone and the FDA
Joffe, Hylton V.
Parks, Mary H.
Meyer, Robert J.
Jenkins, John K.
Temple, Robert
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (17): : 1775 - 1776

← 1 2 3 4 5 →